Depression affects millions of people and can have a significant impact on daily life, relationships, work, and overall well-being. While traditional antidepressant medications have helped many individuals manage their symptoms, they do not work the same way for everyone. Some people continue to experience depression despite trying one or more medications, leading healthcare providers to explore additional treatment options.



One of those options is Spravato® (esketamine), a prescription medication approved for certain adults with treatment-resistant depression and other specific indications. Although both Spravato® and traditional antidepressants are used in the treatment of depression, there are important differences between them.

Understanding those differences can help patients have more informed conversations with their healthcare providers.

Traditional Antidepressants Have Been a Longstanding Treatment Option

Traditional antidepressants have been used for decades and remain an important part of depression treatment.

These medications generally work by affecting neurotransmitters in the brain, such as serotonin, norepinephrine, and dopamine. Depending on the specific medication, the goal is to help regulate mood and reduce depressive symptoms over time.

Many individuals benefit from these medications and experience meaningful improvements in their symptoms. However, responses vary from person to person, and not every patient achieves the desired results with traditional antidepressant therapy alone. This variability is one reason treatment plans are often highly individualized.

Spravato® Uses a Different Active Ingredient

One of the most significant differences between Spravato® and traditional antidepressants is the medication itself.



Spravato® contains esketamine, which is distinct from the active ingredients found in conventional antidepressant medications. Because it works differently within the brain, Spravato® represents an alternative approach for certain patients whose depression has not responded adequately to previous treatments.

Researchers continue to study the complex mechanisms involved in depression and how different treatments may help different individuals. The availability of multiple treatment options allows providers to develop more personalized care plans.

Administration Is Different

Traditional antidepressants are typically taken at home in pill form according to a prescribed schedule. Spravato® is administered differently.

Treatment occurs in a certified healthcare setting under medical supervision. Patients self-administer the nasal spray during their appointment and remain under observation afterward as required by the treatment protocol.

Because of this monitoring requirement, Spravato® treatment involves regular visits to a qualified treatment center. This structured process helps ensure patient safety and compliance with established treatment guidelines.

Eligibility Requirements Differ

Not every depression treatment is appropriate for every patient.



Traditional antidepressants are often among the first treatment approaches considered when someone is diagnosed with depression. Spravato® is generally reserved for patients who meet specific eligibility criteria established by healthcare providers and regulatory guidelines.

A thorough evaluation helps determine whether a patient may be an appropriate candidate. This assessment typically considers medical history, previous treatment experiences, current symptoms, and other relevant factors.

Comprehensive Care Remains Important

Regardless of the treatment approach, depression care often involves more than a single medication.

Mental health treatment plans may include psychiatric evaluations, medication management, psychotherapy, lifestyle considerations, and other supportive interventions. The goal is to address each patient’s unique needs and circumstances.

Spravato® is often incorporated into a broader treatment strategy rather than serving as a standalone solution. This individualized approach reflects the reality that depression affects people differently and may require different forms of care.

The Importance of Exploring Options

One of the most encouraging developments in modern psychiatry is the growing number of treatment options available to patients.

While traditional antidepressants continue to help many individuals, alternative treatments such as Spravato® have expanded the range of possibilities for certain patients who continue to struggle with symptoms despite previous treatment efforts.



The availability of multiple approaches allows healthcare providers to tailor treatment plans more effectively.

Personalized Care Matters

Depression is a complex medical condition, and successful treatment often requires a personalized approach. Understanding the differences between Spravato® and traditional antidepressants can help patients better understand their options and participate more actively in discussions about their care.

Connecticut TMS LLC provides comprehensive mental health services, including Spravato® treatment and Transcranial Magnetic Stimulation (TMS) for appropriate candidates. Through individualized evaluations and patient-centered care, the practice helps patients explore treatment options that align with their unique needs and treatment history.



The most important takeaway is that depression treatment is not one-size-fits-all. As mental health care continues to evolve, patients have access to more options than ever before, creating new opportunities for personalized and effective care.